Robert Studholme - 16 Mar 2022 Form 3 Insider Report for STAAR SURGICAL CO (STAA)

Role
Senior VP,Operations
Signature
/s/Samuel Gesten as Attorney-in-Fact for Robert Studholme
Issuer symbol
STAA
Transactions as of
16 Mar 2022
Net transactions value
$0
Form type
3
Filing time
05 Jul 2022, 21:54:51 UTC
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding STAA Common Stock 20,850 16 Mar 2022 Direct F1
holding STAA Common Stock 502 16 Mar 2022 By spouse.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding STAA Common Stock Options 16 Mar 2022 Commmon Stock 12,547 $74.80 Direct F2
holding STAA Common Stock Options 16 Mar 2022 Common Stock 4,879 $90.38 Direct F3
holding STAA Common Stock Options 16 Mar 2022 Common Stock 14,629 $27.53 Direct F4
holding STAA Common Stock Options 16 Mar 2022 Common Stock 24,284 $35.98 Direct F5
holding STAA Common Stock Options 16 Mar 2022 Common Stock 2,368 $29.80 Direct F5
holding STAA Common Stock Options 16 Mar 2022 Common Stock 10,015 $16.15 Direct F5
holding STAA Common Stock Options 16 Mar 2022 Common Stock 10,000 $9.30 Direct F5
holding STAA Common Stock Options 16 Mar 2022 Common Stock 10,000 $7.36 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Of these, 9,917 are restricted shares subject to forfeiture rights, of which 2,010 will vest on 03/07/2023, 769 will vest on 03/12/2023, 2,346 will vest on 03/20/2023, 2,011 will vest on 03/07/2024, 770 will vest on 03/12/2024, and 2,011 will vest on 03/07/2025.
F2 The options become exercisable as follows: 1/3 on 3/7/2023 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/7/2025.
F3 The options become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024.
F4 The options become exercisable as follows: 1/3 on 3/20/2021, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.
F5 All options became exercisable on or before the stated date.